Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 9, 2008 - Issue 16
Submit an article Journal homepage
60
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Effect of rimonabant, micronised fenofibrate and their combination on cardiometabolic risk factors in overweight/obese patients: a pilot study

M Florentin University of Ioannina, Medical School, Department of Internal Medicine, 45110, Ioannina, Greece +30 26510 97509; +30 26510 97016; [email protected]
,
EN Liberopoulos University of Ioannina, Medical School, Department of Internal Medicine, 45110, Ioannina, Greece +30 26510 97509; +30 26510 97016; [email protected]
,
TD Filippatos University of Ioannina, Medical School, Department of Internal Medicine, 45110, Ioannina, Greece +30 26510 97509; +30 26510 97016; [email protected]
,
C Kostara University of Ioannina, Medical School, Laboratory of Clinical Chemistry, 45110, Ioannina, Greece
,
A Tselepis University of Ioannina, School of Chemistry, Laboratory of Biochemistry, 45110, Ioannina, Greece
,
DP Mikhailidis University College London, Royal Free Hospital, Vascular Disease Prevention Clinics, Department of Clinical Biochemistry London, UK
&
M Elisaf University of Ioannina, Medical School, Department of Internal Medicine, 45110, Ioannina, Greece +30 26510 97509; +30 26510 97016; [email protected]
, MD FASA FRSH show all
Pages 2741-2750 | Published online: 20 Oct 2008

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

T. D. Filippatos, M. Florentin, M. Georgoula & M. S. Elisaf. (2017) Pharmacological management of diabetic dyslipidemia. Expert Review of Clinical Pharmacology 10:2, pages 187-200.
Read now
Theodosios D Filippatos & Moses S Elisaf. (2015) Safety considerations with fenofibrate/simvastatin combination. Expert Opinion on Drug Safety 14:9, pages 1481-1493.
Read now
Theodosios D Filippatos & Moses S Elisaf. (2011) Fenofibrate plus simvastatin (fixed-dose combination) for the treatment of dyslipidaemia. Expert Opinion on Pharmacotherapy 12:12, pages 1945-1958.
Read now

Articles from other publishers (8)

Ioanna Paspala, Niki Katsiki, Dorothea Kapoukranidou, Dimitri P Mikhailidis & Anna Tsiligiroglou-Fachantidou. (2012) The Role of Psychobiological and Neuroendocrine Mechanisms in Appetite Regulation and Obesity. The Open Cardiovascular Medicine Journal 6:1, pages 147-155.
Crossref
Anastazia A. Kei, Theodosios D. Filippatos, Vasilios Tsimihodimos & Moses S. Elisaf. (2012) A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease. Metabolism 61:7, pages 906-921.
Crossref
Georgios A. Christou, Constantinos C. Tellis, Moses S. Elisaf, Alexandros D. Tselepis & Dimitrios N. Kiortsis. (2011) The Changes in Plasma Retinol-Binding Protein 4 Levels are Associated With Those of the Apolipoprotein B-Containing Lipoproteins During Dietary and Drug Treatment. Angiology 63:1, pages 67-75.
Crossref
Anatol Kontush & M. John Chapman. 2011. High‐Density Lipoproteins. High‐Density Lipoproteins 524 532 .
Matilda Florentin, Evangelos N. Liberopoulos, Costas C. Tellis, Christos S. Derdemezis, Moses Elisaf & Alexandros Tselepis. (2009) Effects of Rimonabant, as Monotherapy and in Combination With Fenofibrate or Ezetimibe, on Plasma Adipokine Levels: A Pilot Study. Angiology 61:4, pages 365-371.
Crossref
Theodosios D Filippatos. (2010) Combination drug treatment in patients with non-alcoholic fatty liver disease. World Journal of Hepatology 2:4, pages 139.
Crossref
Theodosios D Filippatos. (2010) Combination drug treatment in obese diabetic patients. World Journal of Diabetes 1:1, pages 8.
Crossref
Matilda Florentin, Michael S. Kostapanos, Eleni S. Nakou, Moses ElisafEvangelos N. Liberopoulos. (2009) Efficacy and Safety of Ezetimibe Plus Orlistat or Rimonabant in Statin-Intolerant Nondiabetic Overweight/Obese Patients With Dyslipidemia. Journal of Cardiovascular Pharmacology and Therapeutics 14:4, pages 274-282.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.